Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...

Forty high school students, including four from Nassau County, have been selected as finalists for the annual Regeneron ...

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...